Clostridium difficile diarrhoea associated with chemotherapy for ovarian cancer

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 37, Issue 3, 1997, Pages 348-349

  Paterson, David L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; METRONIDAZOLE; TOPOTECAN; VANCOMYCIN;

ADULT; ARTICLE; BACTEREMIA; CASE REPORT; CLOSTRIDIUM DIFFICILE; DIARRHEA; FEMALE; HUMAN; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; OVARY CANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STAPHYLOCOCCUS AUREUS;

EID: 0030795244     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1997.tb02428.x     Document Type: Article

References (7)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Eng J Med 1994; 330:257-262.
2. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993; 17:109-113.
3. Nielsen H, Daugaard G, Tvede M, Bruun B. High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer. Br J Cancer 1992; 66:666-667.
4. Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K. Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol 1996; 61:369-372.
5. Satin AJ, Harrison CR, Hancock KC, Zahn CM. Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy. Obstet Gynecol 1989; 74:487-489.
6. Miller SD, Koornhof HJ. Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol 1984; 3:10-13.
7. Hycamtin (topotecan) product information. SmithKline Beecham Consumer Healthcare, Pittsburgh, PA.